It’s not new – 2001 – Doctor Investigated for Using Basal Temperature Test and Natural Dessicated Thyroid

BBC News  – Health – May 17, 2001

Investigation into thyroid doctor
testing

Tests for thyroid deficiency are controversial

A doctor offering controversial treatments for thyroid problems has been suspended from practice by the General Medical Council.

GP Dr Barry Durrant-Peatfield, 64, who has a practice in Purley, Surrey, has been stopped from working for 18 months so that the GMC can complete its investigation.

This may or may not lead to disciplinary action, although Dr Durrant-Peatfield says he cannot afford to fight to clear his name, and plans to retire.

He now cannot treat or prescribe medicines for patients unless the suspension is lifted, and told BBC News Online he was “outraged” by the decision.

“All the GMC wants to see is my head on a spike,” he said.

Dr Durrant-Peatfield, who works outside the NHS, is a controversial figure in thyroid medicine, offering treatments which are actively opposed by many other endocrinologists.

The complaints to the GMC allege that the private GP had failed to examine patients properly, and gone on to prescribe inappropriate drugs.

He has received vociferous support prior to the GMC hearing on Friday from a large number of past and present patients who wrote to the organisation praising him.

Many say their lives have been transformed for the better by his treatment regimes.

One, Linda Thipthorp, from Truro in Cornwall, said that treatments from other doctors, involving radical surgery, had done nothing to improve her condition.

‘My health is still improving’

She said: “After being successively treated by the NHS I could not walk, only crawl about on my hands and knees.

“To be asleep was the only way I could cope with the pain.”

“Dr Peatfield diagnosed immediately what some 20 other doctors had failed to do. After three days I began to feel alive again and my health is still improving nearly three years later.”

The controversy centres around the diagnosis, and treatment of patients with hypothyroidism – a condition in which the thyroid gland in the neck is not functioning properly.

Patients diagnosed with the condition have a slow metabolic rate and are normally given supplements of the hormones produced by the gland to make up for the deficiency.

Dr Durrant-Peatfield prescribed a “natural” form of thyroid hormone – which is derived from the glands of animals, and given in dessicated form.

This was the form in which thyroid hormones were originally produced at the turn of the century, but were phased out in this country, with many doctors now saying that synthetically-produced hormone is best.

This, they say, is because it is difficult to know exactly the concentration of hormone that is being delivered by the natural form.

In addition, Dr Durrant-Peatfield believes that standard thyroid function tests used by the majority of doctors are unreliable.

Basal temperature

He recommends heavier reliance on something called the “basal temperature test”, which involves measuring the internal temperature on waking.

Conversely, many other doctors treating thyroid patients maintain that blood tests for thyroid function are reliable and accurate, and that it is the basal temperature test that is misleading.

However, Dr Durrant-Peatfield said it was “impossible” to misdiagnose a patient if a proper clinical history was taken.

“Blood tests are appropriate in some cases, but I don’t necessarily believe them,” he said.

If patients who do not actually have hypothyroidism are given, over a long period, extra hormones when they do not need them over a long period, there is thought to be an increased risk of bone density loss – which could make patients’ bones more brittle.

There is also thought to be an increased risk of heart problems in these circumstances.

However, the GP insists that there is no evidence of any of his patients suffering physical harm as a result of his treatments.

He said: “I am totally and utterly devastated about this, both for my own sake, and for my patients, who now cannot receive their treatment.”

A spokesman for the GMC confirmed the 18-month suspension by its Interim Orders Committee.

 

Mary Shoman Interviews Dr Kenneth Wolinger – New Hypothyroidism Guidelines Ignore Patient Concerns

Kenneth Woliner, MD is an integrative physician in private practice in Boca Raton, Florida, who uses conventional medicine as well as evidence-based complementary and alternative therapies to treat a variety of conditions, including hypothyroidism. Dr. Woliner has concerns about the American Thyroid Association (ATA) new “Guidelines for the Treatment of Hypothyroidism,” and has shared them in this Q&A interview.

Dr Wollinger: I think they are misnamed. Instead of being called “Guidelines for the Treatment of Hypothyroidism,” this white paper should have been called “Levothyroxine: How to Protect its Market Share.” Simply put, the entire paper, starting with its “Background Statement” is a defense of levothyroxine monotherapy, despite the general dissatisfaction that many patients have when faced with no choices, and told there is only one possible drug to treat their medical conditions.

See the whole interview at:

http://thyroid.about.com/od/Treatments/fl/Dr-Kenneth-Woliner-New-Hypothyroidism-Guidelines-Ignore-Patient-Concerns.htm

Public Support and New Research Promote Changes in Thyroid Treatment Guidelines

Gary Pepper M.D.    Metabolism.com    October 21, 2014

Clearly this is not an endorsement for the use of desiccated thyroid but it does open the door for its use when the clinical situation is appropriate. Until now, a prescriber could face the accusation of recommending toxic treatment, if held to the AACE standard.

In overturning the prior ban on Armour the new AACE recommendations refer to a study done at the NIH by Hoang and colleagues published in May 2013 in  Clinical Endocrinology and Metababolism  which showed that desiccated thyroid could be used safely and effectively in treatment of hypothyroidism.  In this study, about 50% of the individuals treated at different times with levothyroxine and Armour preferred Armour, while 19% preferred levothyroxine. Since the time of publication of the NIH study, Paul Cassanova-Romero  and myself, published our study showing that almost 80% of people who had inadequate relief of hypothyroid symptoms on levothyroxine, preferred Armour Thyroid treatment.

In explaining the new stance of the AACE on use of desiccated thyroid, the committee also referenced a growing understanding of the diverse genetic factors controlling how the body utilizes and responds to thyroid hormone. Due to genetically programmed differences it is plausible that a portion of the hypothyroid population would require treatment with supplemental T3 (as opposed to  Synthroid or levothyroxine made of the hormone T4) supplied by Armour. In addition, desiccated thyroid contains other hormones which could be important to achieving full clinical benefits of thyroid replacement therapy. Genetic testing is not yet at a point where this could be used to determine who needs the addition of T3.

As far as the AACE’s stated concern about safety of Armour Thyroid, it seems strange that desiccated thyroid which has been in use for 100 years is questioned while the synthetic thyroid preparations available for merely half that time, are not being held to the same safety standards.

I have made a request to the organizers of the yearly national meeting of endocrinologist, to allow presentation of our study on patient preference for Armour Thyroid.  Several weeks have gone by without response to our request, however.  A public campaign will help assure the new information reaches the nation’s endocrinologists. For this purpose please email Sheila Spitola, administrator for the national meeting,  (sspatola@aace.com)   , with the statement,   “ I support an open discussion of use of desiccated thyroid in the treatment of hypothyroidism.  The authors of Conversion to Armour Thyroid from Levothyroxine Improved Patient Satisfaction in the Treatment of Hypothyroidism,  should be given the opportunity to present their data at the 2015 national AACE meeting. “

http://www.metabolism.com/2014/10/21/public-support-and-new-research-promote-changes-in-thyroid-treatment-guidelines/#more-21444

 

 

Cold hands? Always tired? It could be the hidden thyroid problem many doctors refuse to treat

From  The Daily Mail – by Jerome Burne, 26 August 2012, Updated 29 August 2014

1 in 20 – The proportion of people in the UK affected by thyroid disorders

A decade ago, Lilian Swallow got very ill, with a long list of complaints. ‘At my worst, I had an irritable bowel, my hair was falling out and I was so tired that just making a cup of tea exhausted me.’

Her GP sent her for various tests but they all came back negative.

‘Eventually, he decided I must be depressed and that it was all in my head,’ says Lilian, now 75. ‘But that didn’t seem right. I was so weak, I couldn’t even pick up my baby granddaughter. Friends never called after 9pm, as they knew I’d be asleep.’

Lilian, a retired legal secretary, sought the advice of another doctor, who checked her thyroid and found one crucial form of thyroid hormone was present in very low levels. She was prescribed a hormone replacement and ‘the effect was astounding. Within a few weeks all my symptoms started to clear up’.

However, the thyroid hormone Lilian was lacking is not normally screened for by the NHS, and the treatment she received is contrary to official guidelines – although a growing number of doctors disagree.

Every year, one in four people in Britain has a standard blood test to see if their thyroid hormone levels are normal. Three million are told they are thyroid deficient (or hypothyroid), and the majority are successfully treated with a synthetic version of the thyroid hormone, known as T4.

But patient groups and some experts claim the test is unreliable because it measures only one thyroid hormone. In fact there are two. The thyroid gland produces T4, which is checked in the blood test. This is then converted into T3 – the active hormone that can be used by the body’s tissues and cells.

People such as Lilian can be fine for T4 but low in T3. However, the T3 tests are complex and rarely offered by the NHS.

So, if your blood test doesn’t show you to be low in T4, you won’t be prescribed thyroid hormones that could alleviate your symptoms, including fatigue, weight gain, cold extremities, muscle aches and weakness. Instead, these symptoms are often dismissed as being ‘all in the mind’.

It is estimated that 300,000 people, mostly women, are in this position.

Official policy advises they shouldn’t get thyroid hormone replacement because they aren’t deficient – despite not knowing what their T3 levels are – and that giving them the drug could cause an overdose or damaging side-effects such as raised blood pressure.

If your blood test doesn’t show you to be low in T4, you won’t be prescribed thyroid hormones that could alleviate your symptoms, including fatigue, weight gain, cold extremities and muscle aches

This leaves doctors in a difficult position. Only around 100 are prepared to treat these people. One is Professor Stafford Lightman, a senior endocrinologist at Bristol University, who believes that there is a case for giving these patients either form of thyroid hormone.

‘Many of my patients are angry,’ he says. ‘They’re convinced doctors aren’t going to take them seriously.

‘But we don’t have a reliable blood test to tell us if enough T3 is getting into tissues. If it is, then an excess can cause harm, but if it isn’t, that’s when patients should be treated.’

T3 is given as a treatment to some patients, but mainly those who have had thyroid cancer.

Sheila Turner, chairwoman of the charity Thyroid Patient Advocacy, is fundraising for a legal challenge to the guidelines. ‘My blood tests show my thyroid levels are normal, but I can only campaign as hard as I do because I get a hormone supplement from a supportive doctor. Without it I’d be on the floor, almost paralysed with fatigue,’ she says.

She wants endocrinologists to accept there are two sorts of hypo-thyroidism – the ‘official’ sort that affects 85 per cent of patients, and those with ‘Low T3 Syndrome’. She explains: ‘We produce enough T4 but don’t turn it into T3 at all well.’

However, she and other patients may have their supply of T3 withdrawn because of the pressure put on doctors not to prescribe it. In a letter recently sent to the charity, an endocrinologist admitted to feeling ‘vulnerable and fearful’ over reports of medics being struck off or suspended for prescribing an unofficial thyroid remedy.

‘I am withdrawing my name from your list until I have been able to clarify the situation,’ she wrote.

Sheila and her supporters are taking on the Royal College of Physicians and five other bodies, including the Society for Endocrinology and British Thyroid Association. Their combined policy statement says that if a blood test shows you are not deficient in T4, you don’t need a replacement. But Sheila says: ‘It assumes that the only reason people have low thyroid hormones is that their thyroid gland isn’t making enough. It doesn’t allow for the fact that even though you’ve got enough in your blood, not enough is getting into your cells.’

Some experts agree. One is American endocrinologist Dr Kent Holtorf, medical director of the Holtorf Medical Group and the National Academy of Hypothyroidism. He says that as well as people who can’t convert T4 into T3 effectively, other patients don’t benefit from standard thyroid tests either.

‘If you’ve got a chronic disease, you’re going to have less energy for getting thyroid hormone into the cells where it is needed,’ he explains. ‘This could mean you show up as having a normal level in your blood when you actually have a damagingly low level in your cells.’ Depression, obesity, diabetes and auto-immune disease are examples.

The Royal College of Physicians is opposed to treating patients with normal blood levels of T4 because symptoms such as fatigue and weight gain are common in people in their 50s and 60s due to other factors. ‘That’s why the blood test is so useful,’ says a spokesman. ‘If patients get treated for an illness they don’t have, genuine and more serious illnesses such as cancer or liver disease could be missed.’

But one result of withdrawing treatment is that patients are driven to get supplies elsewhere, such as unregulated online pharmacies.

Lilian resorted to buying supplies from the internet when, two years after her health improved, her doctor said her blood levels of thyroid hormones were too high and she was in danger of overdosing. Her dose was cut, and within a few weeks her symptoms returned.

‘Every part of my body had a pain. I was in bed for 20 hours a day. I felt suicidal,’ she recalls. A local hospital was eventually persuaded to do tests for T3, which found her levels to be low again. Lilian was then prescribed a dose she describes as ‘inadequate’, so she tops it up with a hormone bought from a website. ‘I’ve now got more energy than I had at 60,’ she says.

But such reports don’t convince endocrinologists who support the current policy. ‘There’s a strong placebo effect with these patients,’ says Professor Colin Dayan, director of the Institute of Molecular and Experimental Medicine at Cardiff University.

‘I’ve done double-blind studies that have found patients can respond much more strongly to getting thyroid hormone in a trial, even when they have been getting it as a regular treatment. ‘They assume it’s a new and different treatment.’

But Dr Holtorf claims that official bodies haven’t been keeping up with the latest research.

‘I’ve just done a review in The Journal of Restorative Medicine showing why it is not scientific just to rely on the blood test to rule out hypothyroidism in patients who have chronic conditions,’ he says. Now researchers are looking at the possibility that certain patients do better on T3.

Dr Birte Nygaard, of Denmark’s Herlev Hospital, recently produced proposals for treating patients who have symptoms of low thyroid but normal blood levels of T4. She suggests an ‘experimental approach’, giving them added T3 at specialist centres.

Professor Lightman would like to see a similar approach in the UK.

The Royal College of Physicians has always claimed that not being able to convert one hormone into the other isn’t a serious problem – trials showed that when T3 was given to patients already getting T4, it didn’t make any difference.

But Sheila Turner has compiled a register of nearly 3,000 patients who say they remained ill when they got only the T4 hormone, but their symptoms went away when they got T3.

Meanwhile, Lilian is thankful that she got the help she needed.

‘When I was being treated according to the official guidelines I was taking 17 drugs a day and still felt dreadful,’ she says. ‘Now I’m taking one and I feel great.

‘If a doctor hadn’t gone against the guidelines I’d be dead by now. That can’t be right.’

http://www.dailymail.co.uk/health/article-2734215/Cold-hands-Always-tired-It-hidden-thyroid-problem-doctors-refuse-treat.html#ixzz3CcIyIUGD

Inside Health – Conflicted Medicine – BBC Radio 4

BBC Radio 4 recently ran a series of three broadcasts entitled Inside Health, each 28 minutes long, which may be of relevance in Singapore.

  • Programme One, first broadcast 12 August 2014 – Conflicted Medicine: Pharmaceuticals 

Are conflicts of interest in medicine out of control and undermining public trust, or an over-hyped concern? Dr Mark Porter investigates the hidden influences affecting your health.

http://www.bbc.co.uk/programmes/b04d4n8q

  • Programme Two, first broadcast 19 August 2014 – Conflicted Medicine: Specialists & GPs

Dr Mark Porter examines the hidden conflicts of interest that may affect how your GP or specialist treats you. He discovers that the advice patient groups give you is also not immune to the influences of organisations such as pharmaceutical companies.

http://www.bbc.co.uk/programmes/b04dmbws

  • Programme Three, first broadcast  26 August 2014 – Conflicted Medicine: Public Health Campaigns

Dr Mark Porter examines how powerful lobbying groups like the food and alcohol industries steer public health policy in the direction that suits them most.

http://www.bbc.co.uk/programmes/b04f9rdw

 

Sick to Death – Trailer

This short – very moving –  video tells the story of film maker Maggie Hadleigh-West’s struggle with thyroid issues, misdiagnosis and unsuccessful treatment with thyroxine. The doctor she finally found after a struggle of 30 years explained the importance of treating the patient, not the test results, and with the use of natural desiccated thyroid gave Maggie a new life.

(Warning:The movie contains some strong language.)

http://sick2death.com/about-the-filmmaker-project/trailer/

The following comes from the Sick to Death website.

About Sick to Death!

Please Note: This project is a work in progress, and we are currently shooting footage and gathering information for the website and films. Sick to Death! is funded by the Guggenheim Foundation. In Sick to Death!, a multi-platform project incorporating video, animation, medical research and an interactive website, artist Maggie Hadleigh-West exposes her own disturbing, yet determined thirty-year struggle to regain her spiraling health. After seeing hundreds of doctors who either disregarded her symptoms, misdiagnosed or undertreated her, Maggie discovers that her thyroid problem used to be a fully understood medical issue that has become all but erased, and which today leaves more than 59 million people sick and suffering. Follow Maggie into her colorful, unconventional, creative life where she tackles existential milestones, and through the assistance of her team of advisers, including a charismatic doctor, takes on the medical establishment. Participate in the unveiling of a huge body of medical information, which became obscured through the lobbying and business practices of a pharmaceutical giant. At once a deeply intimate portrait and a rousing invitation to seize life and health to the fullest, Sick to Death! invites audiences to turn our diagnoses into a call to arms. The final films will take several forms, including several short films to be distributed online to fans, a 60 minute television film also entitled Sick to Death!, and an interactive website which includes a platform for audiences to connect with one another and to build intentional communities. The project is intended to serve as both a work of art and a resource for millions of individuals around the world suffering from thyroid disease.

http://sick2death.com/about-the-filmmaker-project/about-the-project/

New Call for More Thyroid Options

An interesting article by Sumathi Reddy in The Wall Street Journal, August 5, 2013, which quotes a number of well known thyroid experts and discusses how the standard thyroid therapy does not work for everyone.

Grass roots patient-activist organizations with names like ThyroidChange and Thyroid Patient Advocacy, and the doctor-founded National Academy of Hypothyroidism, say that the current screening test for hypothyroidism leaves out some symptomatic patients and that the main medication used to treat patients, doesn’t always alleviate many symptoms.

They are calling for doctors to be open to other therapies, including a combination of synthetic hormones and the use of natural, animal-based ones.

http://online.wsj.com/news/articles/SB10001424127887324635904578644532652110970

However, this article seems to be best reached by copying and pasting New Call for More Thyroid Options into your browser.

Controversy over treatment of hypothyridism diagnosed in Olympic athletes

An article in The Wall Street Journal,  “U.S. Track’s Unconventional Physician”  (Sara Germano & Kevin Clark) focusses on the work of an “unconventional” endocrinologist, Jeffrey S Brown, who believes that hypothyroidism can be caused in young athletes by the stress of the sport. Questions are raised as to whether Brown’s treatment of this in some star athletes might constitute “doping” in sport.

http://online.wsj.com/news/articles/SB10001424127887323550604578412913149043072

However, patient advocate Mary Shoman takes issue with the article, which she calls  “a poorly researched, innuendo-filled article” on her About page – “Editorial: Controversy Over Diagnosing Hypothyroidism”. She asks “several nationally-known practitioners with expertise in thyroid and hormone balance to share their thoughts regarding this story”.

http://thyroid.about.com/od/hypothyroidismhashimotos/a/Editorial-Controversy-Over-Diagnosing-Hypothyroidism.htm

 

 

My bossy GP has cut my thyroid pills – and it’s left me exhausted

MAIL ONLINE – ASK THE DOCTOR
A patient complains that with the cutting of their dosage symptoms of low thyroid have returned. The doctor’s response includes this paragraph:
 I recall a key lesson taught to me years ago when taking my postgraduate exams. Dr Maurice Pappworth, one of the greatest medical teachers of the past century, used to say that when it came to supplementing the thyroid hormone, ‘treat the patient and not the lab result’ – take into account how the patient feels and do not merely focus on figures on a report.